AlzClipp is a pulmonary nasal device that utilizes a unique method of continuous olfactory stimulation believed to support cognitive health. By targeting the olfactory neurons connected to memory and cognition centers in the brain, it may aid in slowing neural degeneration and enhancing cognitive function. Designed to conform to the nasal structure for comfort, the device can be inserted into the nostrils and used multiple times per day, as part of a suggested routine involving 4–6 applications daily. The product operates without the need for preparation, making it accessible for regular use. Some users follow a routine-based approach with AlzClipp, using the device multiple times per day as recommended — typically 4 to 6 applications daily. This consistent use is intended to provide continuous olfactory stimulation, targeting the neurons connected to memory and cognition centers in the brain. Usage frequency and duration may vary depending on individual cognitive support needs, but the device is designed for comfortable, repeated use throughout the day as part of a personalized cognitive wellness routine. With feedback from a substantial number of users who report improved memory and clarity, AlzClipp may offer a supportive role in managing memory-related challenges. Additionally, it is manufactured in an FDA-registered facility and is indicated to be free of known side effects. Its formulation and consumption protocol are designed as part of a broader approach to maintaining cognitive well-being.